No negative impact of serum IgG4 levels on clinical outcome in 435 patients with primary sclerosing cholangitis from Japan-Reference-Cited by-同舟云学术

No negative impact of serum IgG4 levels on clinical outcome in 435 patients with primary sclerosing cholangitis from Japan

Published:2017-03-04 Issue:4 Volume:24 Page:217-225
ISSN:1868-6974
Container-title:Journal of Hepato-Biliary-Pancreatic Sciences
language:en
Short-container-title:J Hepatobiliary Pancreat Sci

Author:

Tanaka Atsushi¹,Tazuma Susumu²,Nakazawa Takahiro³,Isayama Hiroyuki⁴,Tsuyuguchi Toshio⁵,Inui Kazuo⁶,Takikawa Hajime¹

Affiliation:

1. Department of Medicine; Teikyo University School of Medicine; 2-11-1 Kaga, Itabashi-ku Tokyo 173-8605 Japan

2. Department of General Medicine; Hiroshima University; Graduate School of Medical Science; Programs of Applied Medicine; Clinical Pharmacotherapy; Hiroshima Japan

3. Department of Gastroenterology; Japanese Red Cross Nagoya Daini Hospital; Nagoya Japan

4. Department of Gastroenterology; Graduate School of Medicine; The University of Tokyo; Tokyo Japan

5. Department of Medicine and Clinical Oncology; Graduate School of Medicine; Chiba University; Chiba Japan

6. Department of Internal Medicine; Second Teaching Hospital; Fujita Health University; Nagoya Japan

Funder

Ministry of Health, Labour, and Welfare of Japan

Publisher

Wiley

Subject

Hepatology,Surgery

Reference31 articles.

1. Primary sclerosing cholangitis;Karlsen;Best Pract Res Clin Gastroenterol,2010

2. Primary sclerosing cholangitis;Hirschfield;Lancet,2013

3. Glucocorticosteroids for primary sclerosing cholangitis;Giljaca;Cochrane Database Syst Rev,2010

4. Do steroids help jaundice caused by primary sclerosing cholangitis?;Parkes;J Clin Gastroenterol,2001

5. The challenges in primary sclerosing cholangitis-aetiopathogenesis, autoimmunity, management and malignancy;Weismuller;J Hepatol,2008

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Only repeatedly elevated IgG4 levels in primary sclerosing cholangitis may distinguish a particular patient phenotype;BMC Gastroenterology;2024-08-05

2. Clinical outcomes and reintervention after endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis in absence of cholangitis;Indian Journal of Gastroenterology;2024-07-12

3. Prevalence and clinical profiles of primary sclerosing cholangitis in China: Data from electronic medical records and systematic literature retrieval;Journal of Autoimmunity;2024-07

4. The Role of Immunoglobulin G4 in Outcomes of Primary Sclerosing Cholangitis;Journal of Clinical Medicine;2023-12-22

5. An overview of recent treatment options for primary sclerosing cholangitis;Annals of Gastroenterology;2023